Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment

Bone Cysts Clinical Trial

— KOA-RI  

Official title:

Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment: Clinical and Radiological Outcome

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05075148
• Other study ID #: RECHMPL21_0029
• Status: Enrolling by invitation
• Start date: January 1, 2021
• Est. completion date: March 30, 2022

Study information

• Verified date: July 2021
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to describe the clinical outcomeand the radiological appearance of aneurysmal bone cyst treated by means of interventional radiology procedures (percutaneous sclerosis and endovascular embolization)

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 20
• Est. completion date: March 30, 2022
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion criteria:

• Male of female

• Aging from 0 to 30 years

• With typical aneurysmal bone cyst at initial imaging

• At least one interventional radiology procedure performed

Exclusion criteria:

• No initial surgery

• Patient refuses to participate

Related Conditions & MeSH terms

• Bone Cysts
• Cysts

Intervention

Other:
• radiology
Interventional radiology for aneurysmal bone cyst ( percutaneous alcoholization, vascualr embolisation)

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Difference of size lesion after treatement	Percentage of peripheral reossification after treatment : 0%: no reossification; < 25%: low reossification; Between 25% -50%: Partial reossification; Between 50-75%: significant reossification; > 75%: very significant reossification; 100%: complete reossifcation	day 1
Secondary	Number of pain	Pain measured with Pain scale ( 0 = no pain , 10 = maximum pain)	day 1
Secondary	number of deficience	Number of patients needs second treatment 3- Fracture ? (yes or no)	day 1
Secondary	number of complication	Fracture ? (yes or no)	day 1